Principal Research Fellow
Email: s.wheelwright@sussex.ac.uk
Tel (UK): 01273 873024
Tel (International) +44 1273 873024
Dr Sally Wheelwright
Following a degree in Natural Sciences (Experimental Psychology) at the University of Cambridge, Sally Wheelwright remained in Cambridge to research reading development for a year followed by 15 years of autism research. In 2010, she moved to the Faculty of Medicine at the University of Southampton to develop quality of life questionnaires and complete a PhD, focussing on cancer cachexia (uncontrolled, unintentional weight loss and muscle wasting). In 2017, Sally joined the Macmillan Survivorship Research Group in Health Sciences, University of Southampton to work on prospective longitudinal cohort studies exploring the recovery of health and wellbeing in adults diagnosed with cancer.
Sally joined SHORE-C in October 2021. Her research interests centre round supporting self-management of nutritional care in people with cancer and long term conditions, along with quality of life assessment, health literacy and developing digital interventions.
- I-Prehab
I-Prehab will develop a toolkit to support cancer workers to raise awareness of and encourage participation in prehabilitation, particularly with people from socially deprived and ethnically minoritised communities.
- CHANGES
Development and preliminary evaluation of a web based intervention for people with cancer and unintentional weight loss and their informal carers.
- EORTC QLG educational programme
This project will develop an internationally applicable curriculum for quality of life (QoL) in cancer clinical trials and clinical practice.
- Piccinin C, Aaronson N, Bjordal K, Coens C, Darlington A, …, Wheelwright S, Groenvold M. (2025) Flexibility in patient-reported outcome and health-related quality of life measurement: The EORTC Quality of Life Group measurement strategy, European Journal of Cancer, 220. doi:10.1016/j.ejca.2025.115392. Find it online here 07/04/2025
- Wheelwright S, Minton O, Absolom K, Fairvre-Finn C, Fallowfield L, Gilbert ...Shilling V. (2025) Integrating ePROMs: A Key Opportunity for England's National Cancer Plan. Journal of Cancer Policy (44): 100575 Find it online here 10/03/2025
- Meattini I, De Santis MC, Visani L, Scorsetti M, Fozza A, Meduri B ... Livi L. (2024). Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial. Lancet Oncology, 26 (1): 37-50 Find it online here 12/12/2024
- Bradley L, & Wheelwright S. (2024). The impact of delays in transfer to specialist rehabilitation on outcomes in patients with acquired brain injury. Clinical Rehabilitation; 38 (11): 1552-1558. Find it online here 25/09/2024
- Abedin K, Lean QY & Wheelwright S. (2024) Nutritional self-management in colorectal cancer patients and survivors: A scoping review. Colorectal Disease. 2024; 00: 1-18. Find it online here 30/07/2024
- Watts T, Courtier N, Fry S, Gale N, Gillen E, McCutchan G,... Hopkinson, J. (2024). Access, acceptance and adherence to cancer prehabilitation: a mixed-methods systematic review. J Cancer Surviv. Find it online here 06/05/2024
- Wheelwright SJ, Russ S, Mold F, Armes J & Harder H (2024) Symptomatic presentation of cancer in primary care: a scoping review of patients' experiences and needs during the cancer diagnostic pathway. BMJ Open; 14:e076527. Find it online here 20/03/2024
- Palmieri C, Linden H, Birrell SN, Wheelwright S, Lim E, Schwartzberg LS ... B. Overmoyer (2024). Activity and safety of enobosarm, a novel, oral, selective androgen receptor modulator, in androgen receptor-positive, oestrogen receptor-positive, and HER2-negative advanced breast cancer (Study G200802): a randomised, open-label, multicentre, multinational, parallel design, phase 2 trial. The Lancet Oncology. Find it online here 08/02/2024
- Wheelwright S, Matthews L, Jenkins V, May S, Rea D, Fairbrother P, Gaunt C, Young J, Pirrie S, Wallis M G, Fallowfield L, on behalf of the LORIS Trial Management Group (2023). Recruiting women with ductal carcinoma in situ to a randomised controlled trial: lessons from the LORIS study. Trials; 24(1): 670. Find it online here 14/10/2023
- Davies S, & Wheelwright S. (2023) The impact of jejunostomy feeding on nutritional outcomes after oesophagectomy. Journal of Human Nutrition and Dietetics; 2023: 1- 11. Find it online here 04/10/2023
